Management of persistent Bacteremia caused by methicillin-resistant Staphylococcus aureus:: A survey of infectious diseases consultants

被引：32

作者：

Hageman, Jeffrey C.

Liedtke, Laura A.

Sunenshine, Rebecca H.

Strausbaugh, Larry J.

McDonald, L. Clifford

Tenover, Fred C.

机构：

[1] Ctr Dis Control & Prevent, Atlanta, GA 30033 USA

[2] Oregon Hlth Sci Univ, Vet Affairs Med Ctr, Res Serv, Portland, OR 97201 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2006年 / 43卷 / 05期

关键词：

D O I：

10.1086/506568

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We conducted a survey in 2005 of infectious diseases consultants and asked about persistent bacteremia due to methicillin-resistant Staphylococcus aureus. Many consultants perceived an increase in the frequency of illness, and, when presented with vancomycin minimum inhibitory concentrations approaching the limit of the susceptible range, most consultants indicated that they would switch to newer antimicrobial agents for treatment.

引用

页码：E42 / E45

页数：4

共 13 条

[1]

Bamberger DM, 2005, AM FAM PHYSICIAN, V72, P2474

[2]

Busch DF, 1997, CLIN INFECT DIS, V25, P34, DOI 10.1086/514511

[3] Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus [J].

Charles, PGP ;

Ward, PB ;

Johnson, PDR ;

Howden, BP ;

Grayson, ML .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) :448-451

[4] Staphylococcus aureus endocarditis -: A consequence of medical progress [J].

Fowler, VG ;

Miro, JM ;

Hoen, B ;

Cabell, CH ;

Abrutyn, E ;

Rubinstein, E ;

Corey, GR ;

Spelman, D ;

Bradley, SF ;

Barsic, B ;

Pappas, PA ;

Anstrom, KJ ;

Wray, D ;

Fortes, CQ ;

Anguera, I ;

Athan, E ;

Jones, P ;

van der Meer, JTM ;

Elliott, TSJ ;

Levine, DP ;

Bayer, AS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (24) :3012-3021

[5]

Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145

[6] Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility [J].

Howden, BP ;

Ward, PB ;

Charles, PGP ;

Korman, TM ;

Fuller, A ;

du Cros, P ;

Grabsch, EA ;

Roberts, SA ;

Robson, J ;

Read, K ;

Bak, N ;

Hurley, J ;

Johnson, PDR ;

Morris, AJ ;

Mayall, BC ;

Grayson, ML .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (04) :521-528

[7] Persistence in Staphylococcus aureus bacteremia: Incidence, characteristics of patients and outcome [J].

Khatib, R ;

Johnson, LB ;

Fakih, MG ;

Riederer, K ;

Khosrovaneh, A ;

Tabriz, MS ;

Sharma, M ;

Saeed, S .

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (01) :7-14

[8] SLOW RESPONSE TO VANCOMYCIN OR VANCOMYCIN PLUS RIFAMPIN IN METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ENDOCARDITIS [J].

LEVINE, DP ;

FROMM, BS ;

REDDY, BR .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (09) :674-680

[9] Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy [J].

Moise-Broder, PA ;

Sakoulas, G ;

Eliopoulos, GM ;

Schentag, JJ ;

Forrest, A ;

Moellering, RC .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (12) :1700-1705

[10]

NCCLS, 2006, M100S15 NCCLS

← 1 2 →